Each Corbevax shot will be priced at Rs 145 at government hospitals and facilities.
India has expanded its Covid-19 vaccination drive with the inclusion of children in the age group of 12-14, starting on Wednesday.
Children in the said age group will be administered Corbevax vaccine manufactured by Hyderabad-based Biological E. It is India’s first indigenously developed Receptor Binding Domain (RBD) protein sub-unit vaccine against Covid-19.
“Taking the Covid-19 vaccination campaign of ‘Sabko Vaccine Muft Vaccine’ forward under the leadership of Prime Minister Narendra Modi, the vaccination of children in the age group of 12-14 has started from today. All people of 60 years of age will also be able to get precaution dose from today. Let’s secure the country together, get the vaccine,” Union health minister Mansukh Mandaviya tweeted.
कोरोना से लड़ाई है निरंतर ज़ारी।देश सुरक्षा में निभाए अपनी ज़िम्मेदारी।देशभर में 12-14 आयुवर्ग के बच्चों का कोवि… https://t.co/1ul4zAISxr
— Dr Mansukh Mandaviya (@mansukhmandviya) 1647429561000
Meanwhile, the co-morbidity clause for administering precaution doses to those aged 60 years has been removed and all above 60 years of the age can be administered with precaution dose starting today.
Earlier, the administration of precaution dose was restricted to those above 60 years of age with comorbidities, frontline workers and healthcare workers.
(With inputs from agencies)